Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Schroeder

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Cytotherapy|July 29, 2019
Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapyFranziska Blaeschke, Milan Cedric Paul, Martin Ulrich Schuhmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2025
Identifying Risk Factors for Metachronous Colorectal Cancer in Lynch SyndromeRobert Hüneburg, Karolin Weber, Stefan Aretz, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Communications Medicine|October 31, 2025
Multi-modal omics analysis of a paediatric melanoma highlights mechanisms underlying treatment resistanceMarlena Mucha, Sebastian Bühner, Maurice Loßner, et al.
Lung Cancer (Amsterdam, Netherlands)|October 23, 2025
Distinct genomic profile of pediatric lung carcinoma: High frequency of ALK fusions and TP53 mutations compared to adultsMichael Abele, Anton Karelin, Michaela Pogoda, et al.
BMC Medical Genetics|August 17, 2018
First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implicationsMarkus W Löffler, Julia Steinhilber, Franz J Hilke, et al.
Breast Cancer Research and Treatment|May 30, 2015
HBOC multi-gene panel testing: comparison of two sequencing centersChristopher Schroeder, Ulrike Faust, Marc Sturm, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Breast (Edinburgh, Scotland)|May 22, 2025
Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefitsDennis Witt, Marc Sturm, Antje Stäbler, et al.
Virchows Archiv : an International Journal of Pathology|June 18, 2024
Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control studyStephan Forchhammer, Oltin Tiberiu Pop, Matthias Hahn, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cytotherapy|July 29, 2019
Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapyFranziska Blaeschke, Milan Cedric Paul, Martin Ulrich Schuhmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2025
Identifying Risk Factors for Metachronous Colorectal Cancer in Lynch SyndromeRobert Hüneburg, Karolin Weber, Stefan Aretz, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Communications Medicine|October 31, 2025
Multi-modal omics analysis of a paediatric melanoma highlights mechanisms underlying treatment resistanceMarlena Mucha, Sebastian Bühner, Maurice Loßner, et al.
Lung Cancer (Amsterdam, Netherlands)|October 23, 2025
Distinct genomic profile of pediatric lung carcinoma: High frequency of ALK fusions and TP53 mutations compared to adultsMichael Abele, Anton Karelin, Michaela Pogoda, et al.
BMC Medical Genetics|August 17, 2018
First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implicationsMarkus W Löffler, Julia Steinhilber, Franz J Hilke, et al.
Breast Cancer Research and Treatment|May 30, 2015
HBOC multi-gene panel testing: comparison of two sequencing centersChristopher Schroeder, Ulrike Faust, Marc Sturm, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Breast (Edinburgh, Scotland)|May 22, 2025
Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefitsDennis Witt, Marc Sturm, Antje Stäbler, et al.
Virchows Archiv : an International Journal of Pathology|June 18, 2024
Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control studyStephan Forchhammer, Oltin Tiberiu Pop, Matthias Hahn, et al.
Pageof 8